Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study

相似書籍

• Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base
  由: D’Urzo, Anthony D., et al.
  出版: (2019)
• Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
  由: Bateman, Eric D., et al.
  出版: (2015)
• Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
  由: Singh, Dave, et al.
  出版: (2014)
• Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date
  由: Moitra, Subhabrata, et al.
  出版: (2015)
• Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD
  由: Ramos, Mafalda, et al.
  出版: (2016)